Relationship between maternal serum C-reactive protein, funisitis and early-onset neonatal sepsis

The aim of this study was to determine whether maternal serum C-reactive protein (CRP) is of value in predicting funisitis and early-onset neonatal sepsis (EONS) in women with preterm labor or preterm premature rupture of membranes (PROM). This retrospective cohort study included 306 consecutive wom...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 27; no. 6; pp. 674 - 680
Main Authors Lee, Sung Youn, Park, Kyo Hoon, Jeong, Eun Ha, Oh, Kyung Joon, Ryu, Aeli, Park, Kyoung Un
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.06.2012
대한의학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to determine whether maternal serum C-reactive protein (CRP) is of value in predicting funisitis and early-onset neonatal sepsis (EONS) in women with preterm labor or preterm premature rupture of membranes (PROM). This retrospective cohort study included 306 consecutive women with preterm labor or preterm PROM who delivered preterm singleton neonates (23-35 weeks gestation) within 72 hr of CRP measurement. The CRP level was measured with a highly sensitive immunoassay. The sensitivity, specificity, positive predictive value, and negative predictive value of an elevated serum CRP level (≥ 8 mg/L) were 74.1%, 67.5%, 32.8%, and 92.4% for funisitis, and 67.7%, 63.3%, 17.2%, and 94.6% for EONS, respectively. Logistic regression analysis demonstrated that elevated levels of serum CRP were significantly associated with funisitis and EONS, even after adjusting gestational age. The maternal serum CRP level obtained up to 72 hr before delivery is an independent predictor of funisitis and EONS in women with preterm labor or preterm PROM. A low serum CRP level (< 8 mg/L) has good negative predictive value in excluding funisitis and EONS, and may therefore be used as a non-invasive adjunct to clinical judgment to identify low-risk patients.
Bibliography:G704-000345.2012.27.6.008
ISSN:1011-8934
1598-6357
DOI:10.3346/jkms.2012.27.6.674